Filing Details
- Accession Number:
- 0001144204-16-076465
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-21 13:55:45
- Reporting Period:
- 2016-01-19
- Filing Date:
- 2016-01-21
- Accepted Time:
- 2016-01-21 13:55:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1488039 | Atossa Genetics Inc | ATOS | Surgical & Medical Instruments & Apparatus (3841) | 264753208 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1552127 | Shu-Chih Chen | C/O Atossa Genetics, Inc. 2300 Eastlake Ave. East, Suite 200 Seattle WA 98102 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-01-19 | 50,000 | $0.20 | 4,318,315 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- Represents 50,000 shares purchased in an at-market transaction directly from Atossa Genetics, Inc.
- Consists of 4,318,315 shares of common stock owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity.